SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · IEX Real-Time Price · USD
4.540
-0.070 (-1.52%)
May 17, 2024, 4:30 PM EDT - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $298.43 million as of May 17, 2024. Its market cap has increased by 0.35% in one year.
Market Cap
298.43M
Enterprise Value
212.13M
1-Year Change
0.35%
Ranking
Category
Stock Price
$4.54
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $298.43M, a decrease of -73.36%. That is a compound annual growth rate of -37.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 296.80M | -1.53% |
| May 16, 2024 | 301.40M | -0.63% |
| May 15, 2024 | 303.30M | - |
| May 14, 2024 | 303.30M | 1.30% |
| May 13, 2024 | 299.40M | -2.35% |
| May 10, 2024 | 306.60M | -2.70% |
| May 9, 2024 | 315.10M | 4.79% |
| May 8, 2024 | 300.70M | -7.45% |
| May 7, 2024 | 324.90M | -1.37% |
| May 6, 2024 | 329.40M | 0.98% |
| May 3, 2024 | 326.20M | -1.57% |
| May 2, 2024 | 331.40M | 0.79% |
| May 1, 2024 | 328.80M | -1.17% |
| Apr 30, 2024 | 332.70M | 0.79% |
| Apr 29, 2024 | 330.10M | 0.61% |
| Apr 26, 2024 | 328.10M | 1.61% |
| Apr 25, 2024 | 322.90M | -2.18% |
| Apr 24, 2024 | 330.10M | - |
| Apr 23, 2024 | 330.10M | 1.01% |
| Apr 22, 2024 | 326.80M | 1.02% |
| Apr 19, 2024 | 323.50M | 3.32% |
| Apr 18, 2024 | 313.10M | -1.04% |
| Apr 17, 2024 | 316.40M | -2.59% |
| Apr 16, 2024 | 324.80M | 2.46% |
| Apr 15, 2024 | 317.00M | -2.82% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kamada | 310.94M |
| Poseida Therapeutics | 310.26M |
| Atea Pharmaceuticals | 308.26M |
| Caribou Biosciences | 307.07M |
| XOMA Corporation | 299.00M |
| TriSalus Life Sciences | 296.17M |
| Xeris Biopharma Holdings | 292.06M |
| Emergent BioSolutions | 291.62M |